Profile
International Journal of Clinical Research & Trials Volume 1 (2016), Article ID 1:IJCRT-101, 4 pages
https://doi.org/10.15344/2456-8007/2016/101
Research Article
Brain Natriuretic Peptide Levels and Long-Term Outcomes in Acute Decompensated Heart Failure

Michiyo Yamano1*, Tatsuya Kawasaki1, Tetsuhiro Yamano2, Tadaaki Kamitani2, Toshiro Kuribayashi3, Hiroki Sugihara1

1Department of Cardiology, Matsushita Memorial Hospital, Osaka, Japan
2Department of Cardiovascular Medicine, Kyoto Prefectural University Graduate School of Medicine, Kyoto, Japan
3Kuribayashi Clinic of Cardiology, Fukuoka, Japan
Dr. Michiyo Yamano, Department of Cardiology, Matsushita Memorial Hospital Sotojima 5-55, Moriguchi, Osaka 570-8540, Japan, Tel.: +81-66992-1231, Fax: +81-66992-4845; E-mail: m.yamano823@gmail.com
27 August 2015; 30 December 2015; 02 January 2016
Yamano M, Kawasaki T, Yamano T, Kamitani T, Kuribayashi T, et al. (2016) Brain Natriuretic Peptide Levels and Long-Term Outcomes in Acute Decompensated Heart Failure. Int J Clin Res Trials 1: 101. doi: https://doi.org/10.15344/2456-8007/2016/101

References

  1. Braunwald E (2008) Biomarkers in heart failure. N Engl J Med 358: 2148- 2159 [CrossRef] [Google Scholar] [PubMed]
  2. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, et al. (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14: 803-869 [CrossRef] [Google Scholar] [PubMed]
  3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, et al. (2009) 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119: e391-479 [CrossRef] [Google Scholar] [PubMed]
  4. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators (2007) Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49: 1943-1950 [CrossRef] [Google Scholar] [PubMed]
  5. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, et al. (2001) A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37: 386-391 [CrossRef] [Google Scholar] [PubMed]
  6. Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, et al. (2004) Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44: 1328-1333 [CrossRef] [Google Scholar] [PubMed]
  7. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, et al. (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43: 635-641 [CrossRef] [Google Scholar] [PubMed]
  8. Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339: 321-328 [CrossRef] [Google Scholar] [PubMed]
  9. Daniels LB, Maisel AS (2007) Natriuretic peptides. J Am Coll Cardiol 50: 2357-2368 [CrossRef] [Google Scholar] [PubMed]
  10. Regen DM (1990) Calculation of left ventricular wall stress. Circ Res 67: 245-252 [CrossRef] [Google Scholar] [PubMed]
  11. Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102: 470-479 [CrossRef] [Google Scholar] [PubMed]
  12. Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22: 6A-13A [CrossRef] [Google Scholar] [PubMed]
  13. JCS Joint Working Group. Guidelines for Treatment of Acute Heart Failure (JSC 1998-1999) (2000) Jpn Circ J 64:S1129-S1165
  14. Hadase M, Azuma A, Zen K, Asada S, Kawasaki T, et al. (2004) Very low frequency power of heart rate variability is a powerful predictor of clinical prognosis in patients with congestive heart failure. Circ J 68: 343-347 [CrossRef] [Google Scholar] [PubMed]
  15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463 [CrossRef] [Google Scholar] [PubMed]
  16. Teichholz LE, Kreulen T, Herman MV, Gorlin R (1976) Problems in echocardiographic volume determinations: echocardiographicangiographic correlations in the presence of absence of asynergy. Am J Cardiol 37: 7-11 [CrossRef] [Google Scholar] [PubMed]
  17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57: 450-458 [CrossRef] [Google Scholar] [PubMed]
  18. Shuter B, Aslani A (2000) Body surface area: Du Bois and Du Bois revisited. Eur J Appl Physiol 82: 250-254 [CrossRef] [Google Scholar] [PubMed]
  19. Clerico A, Fontana M, Zyw L, Passino C, Emdin M (2007) Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 53: 813-822 [CrossRef] [Google Scholar] [PubMed]